Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
- Publication Information:
Original Publication: [London] : BioMed Central, c2002-
- Subject Terms:
- Comments:
Expression of concern for:Mol Cancer. 2014 Mar 24;13:71. doi: 10.1186/1476-4598-13-71. (PMID: 24655723)
- Accession Number:
0 (MicroRNAs)
EC 2.7.10.1 (Receptor, ErbB-2)
EC 2.7.10.1 (Receptor, IGF Type 1)
0 (IGF1R protein, human)
EC 2.7.10.1 (ERBB2 protein, human)
0 (Antineoplastic Agents)
- Publication Date:
Date Created: 20241001 Date Completed: 20241002 Latest Revision: 20241004
- Publication Date:
20241004
- Accession Number:
PMC11443653
- Accession Number:
10.1186/s12943-024-02139-z
- Accession Number:
39354499
No Comments.